Log In
BCIQ
Print this Print this
 

Solaraze, diclofenac

Also known as: HYAL-CT1101

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionTopical gel of hyaluronan and 3% diclofenac
Molecular Target Cyclooxygenases (COX)
Mechanism of ActionNSAID
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationActinic keratosis
Indication DetailsTreat actinic keratosis (AK)
Regulatory Designation
PartnerAlmirall S.A.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$634.2M

$100.6M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2016

$634.2M

$100.6M

0

Get a free BioCentury trial today